Key result
Systemic sclerosis linked to ~3.3-fold higher odds of inpatient mortality in primary AF admissions.
Why the study?
The impact of systemic sclerosis on inpatient mortality and other outcomes in patients admitted primarily for atrial fibrillation was unclear.
Observational (n=821,630)
Yes
Answers are grounded in this paper and cite their sources.
AF with systemic sclerosis may warrant closer inpatient monitoring; hypothesis-generating and should not yet change practice.
PURPOSE: The aim of this study was to compare the outcomes of patients primarily admitted for atrial fibrillation (AFib) with and without a secondary diagnosis of systemic sclerosis (SSc). The primary outcome was inpatient mortality. Hospital length of stay (LOS), total hospital charges, odds of undergoing ablation, and electrical cardioversion were secondary outcomes of interest. METHODS: Data were abstracted from the National Inpatient Sample (NIS) 2016 and 2017 Database. The NIS was searched for adult hospitalizations with AFib as principal diagnosis with and without SSc as secondary diagnosis using International Classification of Diseases, Tenth Revision, Clinical Modification codes. Multivariate logistic and linear regression analysis was used accordingly to adjust for confounders. RESULTS: There were over 71 million discharges included in the combined 2016 and 2017 NIS database. Of 821,630 AFib hospitalizations, 750 (0.09%) had SSc. The adjusted odds ratio for inpatient mortality for AFib with coexisting SSc compared with without coexisting SSc was 3.3 (95% confidence interval, 1.27-8.52; p = 0.014). Atrial fibrillation with coexisting SSc hospitalizations had similar LOS (4.2 vs 3.4 days; p = 0.767), mean total hospital charges ($40,809 vs $39,158; p = 0.266), odds of undergoing ablation (2.7% vs 4.2%; p = 0.461), and electrical cardioversion (12.0% vs 17.5%; p = 0.316) compared with without coexisting SSc. CONCLUSIONS: Patients admitted primarily for AFib with a secondary diagnosis of SSc have more than 3 times the odds of inpatient death compared with those without coexisting SSc. Hospital LOS, total hospital charges, likelihood of undergoing ablation, and electrical cardioversion were similar in both groups.
No takes yet. Share an insight, caveat, or question.
Augustine Mathew Manadan (2020) conducted an observational in Atrial fibrillation (n=821,630). Systemic sclerosis vs. Without systemic sclerosis was evaluated on Inpatient mortality (OR 3.3, 95% CI 1.27-8.52, p=0.014). Patients admitted primarily for atrial fibrillation with coexisting systemic sclerosis had 3.3 times higher odds of inpatient mortality compared to those without systemic sclerosis.
Synapse has enriched 10 related papers. Consider them for comparative context: